Cancer Research SABCS  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3838-3844, August 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sueoka, N.
Right arrow Articles by Kurie, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sueoka, N.
Right arrow Articles by Kurie, J. M.
[Cancer Research 59, 3838-3844, August 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Posttranslational Mechanisms Contribute to the Suppression of Specific Cyclin

CDK Complexes by All-Trans Retinoic Acid in Human Bronchial Epithelial Cells1

Naoko Sueoka, Ho-Young Lee, Garrett L. Walsh, Waun Ki Hong and Jonathan M. Kurie2

Departments of Thoracic/Head and Neck Medical Oncology [N. S., H. Y. L., W. K. H., J. M. K.] and Thoracic and Cardiovascular Surgery [G. L. W.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Retinoids have demonstrated activity in the chemoprevention of aerodigestive tract cancer. Potentially contributing to their lung cancer chemopreventive effects, retinoids inhibit the growth of human bronchial epithelial (HBE) cells. We observed previously that all-trans retinoic acid (t-RA) arrests the growth of HBE cells in the G0 phase of the cell cycle through activation of retinoic acid receptor-dependent pathways, which enhances the association of E2F-4 with retinoblastoma protein family members, converting E2F into a transcriptional suppressor. In this study, we examined the mechanism by which t-RA blocks cell cycle progression in HBE cells and the possibility that this signaling event is blocked in non-small cell lung cancer (NSCLC) cells that are refractory to the growth inhibitory effects of t-RA. t-RA suppressed the expression and activity of cyclin D1, cyclin E, and cyclin-dependent kinases (CDK)-2 and CDK-4, increased expression of the CDK inhibitor p27, and shifted the retinoblastoma protein to a hypophosphorylated form. Posttranslational mechanisms contributed to the changes in CDK-2, CDK-4, and p27 levels, which, in the case of CDK-4, involved the ubiquitin-proteasome pathway. In contrast, despite retinoic acid receptor transcriptional activation, these signaling events did not occur in a NSCLC cell line that is refractory to growth inhibition by t-RA. These findings provide the first evidence that t-RA activates degradation of CDK-4 through the ubiquitin-proteasome pathway, a novel mechanism by which t-RA causes HBE cells to exit the cell cycle, and blockade of these signaling events may contribute to the development of retinoid resistance in NSCLC cells.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
B. Trojanowicz, A. Winkler, K. Hammje, Z. Chen, C. Sekulla, D. Glanz, C. Schmutzler, B. Mentrup, S. Hombach-Klonisch, T. Klonisch, et al.
Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines
J. Mol. Endocrinol., March 1, 2009; 42(3): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ravikumar, G. Perez-Liz, L. Del Vale, D. R. Soprano, and K. J. Soprano
Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid
Cancer Res., October 1, 2007; 67(19): 9266 - 9275.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. H. Dragnev, I. Pitha-Rowe, Y. Ma, W. J. Petty, D. Sekula, B. Murphy, M. Rendi, N. Suh, N. B. Desai, M. B. Sporn, et al.
Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy
Clin. Cancer Res., April 1, 2004; 10(7): 2570 - 2577.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Vuocolo, E. Purev, D. Zhang, J. Bartek, K. Hansen, D. R. Soprano, and K. J. Soprano
Protein Phosphatase 2A Associates with Rb2/p130 and Mediates Retinoic Acid-induced Growth Suppression of Ovarian Carcinoma Cells
J. Biol. Chem., October 24, 2003; 278(43): 41881 - 41889.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Ratschiller, J. Heighway, M. Gugger, A. Kappeler, F. Pirnia, R.A. Schmid, M.M. Borner, and D.C. Betticher
Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival
J. Clin. Oncol., June 1, 2003; 21(11): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. L. Crowe, R. Kim, and R. A.S. Chandraratna
Retinoic Acid Differentially Regulates Cancer Cell Proliferation via Dose-Dependent Modulation of the Mitogen-Activated Protein Kinase Pathway
Mol. Cancer Res., May 1, 2003; 1(7): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Pereira, Y. Li, W. T. Gunning, P. M. Kramer, F. Al-Yaqoub, R. A. Lubet, V. E. Steele, E. Szabo, and L. Tao
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers
Carcinogenesis, July 1, 2002; 23(7): 1185 - 1192.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton
Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents
Carcinogenesis, February 1, 2002; 23(2): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Dow, J. Hendley, A. Pirkmaier, E. A. Musgrove, and D. Germain
Retinoic Acid-mediated Growth Arrest Requires Ubiquitylation and Degradation of the F-box Protein Skp2
J. Biol. Chem., November 30, 2001; 276(49): 45945 - 45951.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. A. Papadimitrakopoulou, J. Izzo, L. Mao, J. Keck, D. Hamilton, D. M. Shin, A. El-Naggar, P. den Hollander, D. Liu, W. N. Hittelman, et al.
Cyclin D1 and p16 Alterations in Advanced Premalignant Lesions of the Upper Aerodigestive Tract: Role in Response to Chemoprevention and Cancer Development
Clin. Cancer Res., October 1, 2001; 7(10): 3127 - 3134.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Miano and B. C. Berk
Retinoids: New Insight Into Smooth Muscle Cell Growth Inhibition
Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 724 - 726.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Sueoka, H.-Y. Lee, G. L. Walsh, B. Fang, L. Ji, J. A. Roth, R. LaPushin, W. K. Hong, P. Cohen, and J. M. Kurie
Insulin-Like Growth Factor Binding Protein-6 Inhibits the Growth of Human Bronchial Epithelial Cells and Increases in Abundance with All-trans-Retinoic Acid Treatment
Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 297 - 303.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.